Discussion
A research team at the University of California, Los Angeles (UCLA) has received a $7.49 million grant to advance a novel cell-based therapy for multiple sclerosis (MS) toward its first clinical trial. The state funding, awarded by the California Institute for Regenerative Medicine (CIRM), was earmarked for a team…